ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 017,86
-0,28%
Dow Jones
38 918,27
0,08%
DAX
18 577,71
-0,37%
Brent Oil
79,855
-0,03%
Bitcoin
71 228,08
0,66%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. CorMedix Inc (CRMD)

  7. CorMedix Inc (CRMD) Actualités

CRMD

CorMedix (CRMD)

CorMedix Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CRMD
DateHeureSourceTitreSymboleSociété
06/06/202414h30GlobeNewswire Inc.CorMedix Inc. Announces CMS Grants Pass-Through Status to DefencathNASDAQ:CRMDCorMedix Inc
23/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CRMDCorMedix Inc
13/05/202422h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
09/05/202423h06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CRMDCorMedix Inc
09/05/202414h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRMDCorMedix Inc
09/05/202413h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
19/04/202414h30GlobeNewswire Inc.CorMedix Inc. Announces CMS Grants TDAPA to DefenCathNASDAQ:CRMDCorMedix Inc
15/04/202414h30GlobeNewswire Inc.CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)NASDAQ:CRMDCorMedix Inc
12/03/202412h30GlobeNewswire Inc.CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
18/01/202422h53Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CRMDCorMedix Inc
14/12/202322h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
14/11/202322h05GlobeNewswire Inc.CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
11/10/202314h30GlobeNewswire Inc.CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek ConferenceNASDAQ:CRMDCorMedix Inc
13/09/202323h26Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CRMDCorMedix Inc
13/09/202323h25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CRMDCorMedix Inc
13/09/202323h20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CRMDCorMedix Inc
08/09/202314h30GlobeNewswire Inc.CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of NephrologyNASDAQ:CRMDCorMedix Inc
30/08/202314h00GlobeNewswire Inc.CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product DefencathNASDAQ:CRMDCorMedix Inc
08/08/202313h30GlobeNewswire Inc.CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
30/06/202322h38Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRMDCorMedix Inc
29/06/202304h57GlobeNewswire Inc.CorMedix Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:CRMDCorMedix Inc
28/06/202323h14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CRMDCorMedix Inc
28/06/202322h07GlobeNewswire Inc.CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:CRMDCorMedix Inc
21/06/202314h43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRMDCorMedix Inc
21/06/202314h30GlobeNewswire Inc.CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCathNASDAQ:CRMDCorMedix Inc
15/06/202314h30GlobeNewswire Inc.Cormedix Inc. Announces Strategic Initiative With Boston Medical Center to Reduce Health Disparities in Patients at Risk for Bloodstream InfectionsNASDAQ:CRMDCorMedix Inc
19/05/202322h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRMDCorMedix Inc
19/05/202300h26Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CRMDCorMedix Inc
16/05/202313h00GlobeNewswire Inc.CorMedix Inc. Announces Resubmission of New Drug Application for DefenCathNASDAQ:CRMDCorMedix Inc
15/05/202322h05GlobeNewswire Inc.CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
 Showing the most relevant articles for your search:NASDAQ:CRMD

Dernières Valeurs Consultées

COIN
ETHUSD
Ethereum
EU
AI
Air Liquide
EU
CS
Axa
EU
PX1
CAC 40
EU
MC
Lvmh Moet Hennessy Louis...
EU
VK
Vallourec
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
EU
EN
Bouygues
COIN
BTCUSD
Bitcoin
EU
SGO
Cie de SaintGobain
SPI
SP500
S&P 500
EU
HO
Thales
FTSE
UKX
FTSE 100
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés